New pill shows promise for tough blood cancers

NCT ID NCT05147467

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called APG-2575 in people whose chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) has come back or stopped responding to other treatments. About 75 adults will take the drug alone to see if it can shrink tumors and control the disease. The goal is to find a new option for patients who have run out of effective therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hainan General Hospital

    NOT_YET_RECRUITING

    Haikou, Hainan, 570311, China

  • Henan Cancer Hospital

    RECRUITING

    Zhengzhou, Henan, 450003, China

  • Institute of blood transfusion of Chinese Academy of Medical Sciences

    NOT_YET_RECRUITING

    Tianjin, Tianjin Municipality, 215127, China

  • Nanfang Hospital of Southern Medical University

    RECRUITING

    Guangzhou, Guangdong, 510515, China

  • People's hospital of Jiangsu Province

    NOT_YET_RECRUITING

    Suzhou, Jiangsu, China

  • Sun Yat-sen University Cancer Center

    RECRUITING

    Guangzhou, Guangdong, 510060, China

  • The First Affilated Hospital of Nanchang University

    NOT_YET_RECRUITING

    Nanchang, Jiangxi, 330006, China

  • The First Affilated Hospital of Soochow University

    NOT_YET_RECRUITING

    Suzhou, Jiangsu, 215006, China

  • The First Affiliated Hospital of Zhejiang University School of Medicine

    NOT_YET_RECRUITING

    Hanzhou, Zhejiang, 310003, China

  • Union Hospital medical college Huazhong University of Science and Technology

    RECRUITING

    Wuhan, Hubei, 430022, China

  • Zhujiang Hospital of Southern Medical University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510280, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.